An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
Clinical trial NCT06675955 · RECRUITING
Trial details
- NCT number
- NCT06675955
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2029-12-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.